scholarly journals Long-term compression therapy in patients with chronic venous diseases - fantasy and realityIntroduction

2018 ◽  
Vol 20 (2) ◽  
pp. 93-95
Author(s):  
Leo Puszkailer ◽  
Jan Bialek ◽  
Dalibor Musil ◽  
Kateřina Langová
Phlebologie ◽  
2010 ◽  
Vol 39 (03) ◽  
pp. 133-137
Author(s):  
H. Partsch

SummaryBackground: Compression stockings are widely used in patients with varicose veins. Methods: Based on published literature three main points are discussed: 1. the rationale of compression therapy in primary varicose veins, 2. the prescription of compression stockings in daily practice, 3. studies required in the future. Results: The main objective of prescribing compression stockings for patients with varicose veins is to improve subjective leg complaints and to prevent swelling after sitting and standing. No convincing data are available concerning prevention of progression or of complications. In daily practice varicose veins are the most common indication to prescribe compression stockings. The compliance depends on the severity of the disorder and is rather poor in less severe stages. Long-term studies are needed to proof the cost-effectiveness of compression stockings concerning subjective symptoms and objective signs of varicose veins adjusted to their clinical severity. Conclusion: Compression stockings in primary varicose veins are able to improve leg complaints and to prevent swelling.


2007 ◽  
Vol 13 (2) ◽  
pp. 88-102 ◽  
Author(s):  
Svetlana Milosavljevic ◽  
Petar Skundric

Although compression therapy is a key factor in the successful treatment of some circulatory problems in lower limbs, this form of therapy includes some risks if used inappropriately. Based on deliberate application of pressure to a lower limb, using a variety of textile materials, elastic or rigid, in order to produce a desired clinical effects, modern compression therapy presents a good sample of successful penetration of textile technology into the phlebology field of medicine. However, although compression therapy has been in use for over 150 years, there exists a low awareness among practitioners and patients on product usage, application techniques and benefits of appropriate selection of bandages for determined types of leg venous diseases. Also, not all manufacturers of compression textile materials seem to be conscious of end - users' needs. Simultaneously, impressive developments in the field of elastan fibers and modern knitting and weaving technologies, offer chances for realization of completely new types of compression bandages, capable of making an important contribution to the management of venous disease. In this review, starting from the brief account of pathogenesis and the presentation of compression therapy principle, an account of the contribution of all sectors in the textile technological chain to a modern compression therapy is given.


VASA ◽  
2003 ◽  
Vol 32 (Supplement 63) ◽  
pp. 3-6

Background. The use of compression therapy is mainly based on tradition and experience. Randomized controlled trials demonstrating clinical effects in different indications are rare or non-existing. A clear proof of effectiveness for different compression devices endorsed by evidence based medicine will be a prerequisite for reimbursement by health budgets in the near future. Against this background a group of experts has discussed and approved the following position document under the auspices of the International Union of Phlebology. Indications for compression therapy in phlebology and lymphology are mainly: 1. Chronic venous disorders (CEAP C0-C6 ) (1) 2. Acute venous diseases 3. Lymphoedema. The following 3 questions are discussed for every single indication: ¥ What is done? (Current practice and rationale) ¥ What do we know? (Level of recommendation based on present knowledge) ¥ What do we need to know? (Proposals for randomized controlled trials on compression therapy)


2018 ◽  
Vol 49 (2) ◽  
pp. 47-49 ◽  
Author(s):  
Krystyna Zawilska

AbstractUnprovoked venous thromboembolism (VTE) - proximal venous thrombosis or pulmonary embolism - should be treated either 3 months or indefinitely if the risk of bleeding is low. This article summarizes the efficacy and safety of extended therapy of VTE with direct oral anticoagulants (DOAC) in comparison with warfarin, as well as the role of of acetylsalicylic acid (ASA) for the long-term prevention of recurrent VTE. As the Survet study showed, for some patients who have already completed at least 6 months of anticoagulant treatment for their index VTE event, an oral glycosaminoglycan - sulodexide associated with compression therapy is a good choice, because it decreases the incidence of recurrences of VTE without detectable risks for the patients’ safety.


2019 ◽  
Vol 24 (Sup10) ◽  
pp. S24-S31
Author(s):  
Alison Schofield

The cost that chronic wound care imposes on both patients and health services worldwide is well recognised. Most patients with venous leg ulcers require compression therapy over the long term, for both treatment as well as to prevent recurrence of these wounds. Caring for patients with chronic wounds makes up a large part of the workload for district and community nurses, and encouraging self-management among patients is a worthwhile effort to limit the costs and resources directed for this purpose. The present article describes the practical use of the ReadyWrap range of compression garments, which are available in various different styles, and aid patients, their families and carers in the self-management of venous leg ulcers. These products are designed with their long-term use in mind, and, as described in the case studies in this article, patients show good concordance to compression therapy involving ReadyWrap.


2020 ◽  
Vol 25 (Sup9) ◽  
pp. S26-S32
Author(s):  
Jeanette Muldoon ◽  
Sylvie Hampton ◽  
Sarah Gray ◽  
Trish Cosham

Compression therapy for venous and lymphatic conditions may be delivered via a range of treatment modalities using many different technologies, depending on the patient's condition and needs. Clinical decision-making relies on accurate assessment of the patient, their presenting and underlying clinical condition, skill and training of the applier and the available resources. However, changes in the patient's condition or lifestyle may necessitate re-evaluation of the treatment pathway. Generally, compression bandages and Velcro wraps are used in the intensive acute phase of treatment, with self-management using compression hosiery or wraps being used for long-term maintenance to prevent recurrence. Although guidelines recommend the highest class of compression hosiery for maximum effectiveness, clinical evidence shows practical challenges associated with application and tolerance of higher pressures and stiffness. An audit of a new type of compression garment was conducted, and it showed that incorporating stiffness into circular knitted hosiery helped overcome some of these challenges with improvements in limb size, skin softening and wound size. Additionally, self-management was facilitated by the ease of donning and doffing.


BMJ ◽  
2007 ◽  
Vol 335 (7610) ◽  
pp. 83 ◽  
Author(s):  
Manjit S Gohel ◽  
Jamie R Barwell ◽  
Maxine Taylor ◽  
Terry Chant ◽  
Chris Foy ◽  
...  

2014 ◽  
Vol 29 (1_suppl) ◽  
pp. 78-82 ◽  
Author(s):  
AC Bouman ◽  
AJ ten Cate-Hoek

After deep vein thrombosis (DVT) 20-50%, of patients develop post thrombotic syndrome (PTS). Up till now, there is no effective treatment for PTS and prevention is therefore of major importance. Compression therapy after DVT, with elastic compression stockings (ECS), is the only available preventive measure for PTS. However, the usefulness, timing, and duration of compression therapy are matters of debate. The effect of early compression on the long-term development of PTS is still unclear as studies performed so far have conflicting outcomes.16–19 The effectiveness of ECS therapy initiated in the sub-acute phase was assessed in three large randomized controlled trials. Kahn et al could not reproduce the large risk reduction found in the trials by Brandjes and Prandoni et al.20–22 Also for the optimal duration of ECS therapy, a certain conclusion has yet to be drawn. Therefore identification of patients who most likely will benefit from ECS therapy as well as the optimal ECS treatment strategy remain subjects for further study.


Sign in / Sign up

Export Citation Format

Share Document